BİPOLAR HASTALIKLAR HER ZAMAN YAŞAM BOYU İLAÇ KULLANMAYI
GEREKTİRMEYEBİLİR

Conclusion
The proper role of antidepressants in the treatment of bipolar
depression continues to be a topic of deep clinical importance, marred by a
lack of sufficient data with more heated opinions than consistent data-driven
suggestions. We need both short (8–16 weeks) and longer term (6 month to 2
years) studies in both bipolar I and bipolar II patients (Gitlin 2012). Longer
term studies are especially needed for bipolar II patients, given the efficacy
and lack of harm seen in a few longer term (up to 1 year) antidepressant
monotherapy studies (Amsterdam and Shults 2010; Amsterdam et al. 2015). Studies
should include rapid cycling patients given the conflicting data on the
potential harm associated with their use (Ghaemi et al. 2010; Amsterdam et al.
2013; Altshuler et al. 2017). Optimally, active comparators—lithium,
lamotrigine, second generation antipsychotics should be included in the design
of these studies. Until we have a larger data base, the question of
antidepressants for bipolar depression will continue to generate more heat than
light to the detriment of patients and clinicians alike.
Int J Bipolar Disord. 2018; 6: 25.
Published online 2018 Dec 1. doi: 10.1186/s40345-018-0133-9
Antidepressants in bipolar depression: an enduring controversy
Michael J. Gitlin